Stille AB: Interim Report Q2 2021
Revenues for the second quarter increased by 39 percent to 40.6 MSEK (29.3) and operating profit to 5.2 MSEK (-1.5) compared to previous year. The growth is applicable to both Surgical Instruments (44 percent) and C-arm Tables (35 percent).
"I am pleased to see that demand for our products is returning in all markets where we are active, and it is particularly positive that the growth for both business units is the strongest on the strategically important US market", says CEO Hanna Ernestam Wilkman.
Shortly after the end of the second quarter, Stille acquired Suisse S&T AG, a company that develops, manufactures, and markets microsurgical instruments.
"S&T AG meets our high expectations regarding profitability and growth potential. This acquisition is a strong complement to Stille's product portfolio for microsurgery, while S&T AGs distribution network complement Stille's sales channels very well. With the acquisition we double the size of our Surgical Instruments business unit. The 180th business year is undeniably a milestone in Stille's growth journey and I am very optimistic about the future", notes Stille's CEO.
- Revenues amounted to 40.6 MSEK (29.3).
- Gross margin amounted to till 45.4 percent (28.9).
- Operating profit amounted to 5.2 MSEK (-1.5), equal to an operating margin of 12.7 percent (-5.1). The operating profit was impacted with -0,8 MSEK (0.0) in transaction costs.
- Net income amounted to 2.7 MSEK (-2.0), equal to 6.7 percent (-7.0) of revenues.
- Cashflow from current operations amounted to -3.0 MSEK (0.6).
MSEK apr-jun apr-jun jan-jun jan-jun jul-jun jan-dec
2021 2020 2021 2020 20/21 2020
Revenue 40.6 29.3 76.4 66.1 152.9 142.6
Operating Profit 5.2 -1.5 9.1 3.3 20.4 14.5
incl. transaction
costs
Operating Margin 12.7 -5.1 12.0 4.9 13.3 10.2
incl. transaction
costs. %
Profit Before Tax 4.1 -2.4 9.8 3.1 17.5 10.8
Net Income 2.7 -2.0 6.8 2.3 12.7 8.3
Earnings per Share. 0.57 -0.42 1.40 0.48 2.63 1.71
SEK
Torshälla, July 16th, 2021.